Bank of Montreal’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-22,595
| Closed | -$2.31M | – | 3812 |
|
|
2023
Q2 | $2.31M | Buy |
+22,595
| New | +$2.31M | ﹤0.01% | 1473 |
|
|
2021
Q2 | – | Sell |
-545
| Closed | -$51K | – | 4774 |
|
|
2021
Q1 | $51K | Buy |
545
+242
| +80% | +$22.6K | ﹤0.01% | 3303 |
|
|
2020
Q4 | $38K | Buy |
303
+84
| +38% | +$10.5K | ﹤0.01% | 3618 |
|
|
2020
Q3 | $24K | Sell |
219
-134
| -38% | -$14.7K | ﹤0.01% | 3363 |
|
|
2020
Q2 | $55K | Sell |
353
-67
| -16% | -$10.4K | ﹤0.01% | 3042 |
|
|
2020
Q1 | $57K | Sell |
420
-2,537
| -86% | -$344K | ﹤0.01% | 2552 |
|
|
2019
Q4 | $604K | Buy |
2,957
+1,123
| +61% | +$229K | ﹤0.01% | 2148 |
|
|
2019
Q3 | $148K | Buy |
1,834
+5
| +0.3% | +$403 | ﹤0.01% | 2631 |
|
|
2019
Q2 | $173K | Buy |
1,829
+1,759
| +2,513% | +$166K | ﹤0.01% | 2583 |
|
|
2019
Q1 | $6K | Sell |
70
-263
| -79% | -$22.5K | ﹤0.01% | 3595 |
|
|
2018
Q4 | $19K | Buy |
333
+204
| +158% | +$11.6K | ﹤0.01% | 3319 |
|
|
2018
Q3 | $11K | Buy |
129
+16
| +14% | +$1.36K | ﹤0.01% | 3586 |
|
|
2018
Q2 | $4K | Buy |
+113
| New | +$4K | ﹤0.01% | 3865 |
|
|
2016
Q3 | – | Sell |
-5,162
| Closed | -$102K | – | 3868 |
|
|
2016
Q2 | $102K | Buy |
+5,162
| New | +$102K | ﹤0.01% | 2554 |
|